Last updated on November 2017

An Open-Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis


Brief description of study

An Open-Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis

Detailed Study Description

The purpose of this study is to evaluate the safety and tolerability of topical INCB018424 cream applied to pediatric subjects (≥ 12 to 17 years) with atopic dermatitis (AD).

Clinical Study Identifier: TX153343

Contact Investigators or Research Sites near you

Start Over

WAKE RESEARCH ASSOCIATES LLC

WAKE RESEARCH ASSOCIATES LLC
Raleigh, NC USA
  Connect »

David Fivenso, MD, Dermatology, PLLC

David Fivenso, MD, Dermatology, PLLC
Ann Arbor, MI USA
  Connect »

Texas Dermatology and Laser Specialist

Texas Dermatology and Laser Specialist
San Antonio, TX USA
  Connect »

Penn State Dermatology

Penn State Dermatology
Hershey, PA USA
  Connect »

National Jewish Center

National Jewish Center
Denver, CO USA
  Connect »